Package 76420-642-60

{"route": ["ORAL"], "spl_id": "091085d0-280b-a5cc-e063-6294a90a78ce", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["403957"], "spl_set_id": ["51f87c9b-038c-4793-b0d5-5359ae231074"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (76420-642-30)", "package_ndc": "76420-642-30", "marketing_start_date": "20231031"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (76420-642-60)", "package_ndc": "76420-642-60", "marketing_start_date": "20231031"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (76420-642-90)", "package_ndc": "76420-642-90", "marketing_start_date": "20231031"}], "brand_name": "Tadalafil", "product_id": "76420-642_091085d0-280b-a5cc-e063-6294a90a78ce", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "76420-642", "generic_name": "Tadalafil", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tadalafil", "active_ingredients": [{"name": "TADALAFIL", "strength": "5 mg/1"}], "application_number": "ANDA207244", "marketing_category": "ANDA", "marketing_start_date": "20191008", "listing_expiration_date": "20261231"}